ESG Compared with Sleeve Gastrectomy, Gastric Balloon and Weight-Loss Medication

Why Compare Weight-Loss Options

People researching endoscopic sleeve gastroplasty (ESG) are often weighing it against other treatments for obesity. Each option works differently, carries different risks and asks for a different level of long-term commitment. This article focuses on how ESG compares with three common alternatives: surgical sleeve gastrectomy, the intragastric balloon and prescription weight-loss medication. Other bariatric operations, such as gastric bypass, are mentioned only briefly. Weight loss is not the only goal to consider: improvement in related conditions, safety, recovery time and how well each treatment fits daily life all matter. It is a general overview; the best option for any individual can only be determined after a specialist assessment.

Each Option at a Glance

• ESG: the stomach is narrowed from the inside with endoscopic stitches, without incisions or tissue removal. Usually a day-case or overnight procedure.
• Sleeve gastrectomy: a laparoscopic operation that permanently removes a large part of the stomach, leaving a narrow tube. Requires general anaesthesia and a short hospital stay.
• Gastric balloon: a soft balloon placed in the stomach (endoscopically or, with some types, swallowed) and filled with fluid to take up space. It is temporary and removed or passed after a set period, typically months.
• Weight-loss medication: prescription drugs, including GLP-1 receptor agonists and related agents, that reduce appetite and affect how the body handles food. They are taken as long as they are prescribed.

ESG Compared with Sleeve Gastrectomy

Sleeve gastrectomy is an established bariatric operation with a large body of long-term evidence. It generally produces greater and more durable weight loss than ESG, and is often preferred for people with higher body mass index or significant weight-related disease such as type 2 diabetes. In exchange, it is irreversible, involves surgical risks such as staple-line leaks and bleeding, and is associated with new or worsened acid reflux in some people.

ESG does not remove tissue, involves no external incisions, and recovery is usually quicker. Published comparisons suggest fewer serious complications and less new reflux than surgery, but also less weight loss, and long-term durability data are more limited. ESG is generally discussed for people with moderate obesity, or for those who are not suitable for or do not wish to have surgery.

ESG Compared with a Gastric Balloon

Both ESG and the intragastric balloon are endoscopic or non-surgical approaches, and both are typically considered for similar weight ranges. The main difference is permanence. A balloon is designed to be temporary, and some weight regain after removal is common unless habits have changed substantially. ESG is intended as a longer-term modification of the stomach, although stitches can loosen over time.

Balloons can cause marked nausea and vomiting in the first days and, occasionally, may need early removal because of intolerance. ESG carries a small risk of procedure-related complications such as bleeding. Some people use a balloon as a short-term step, for example to reduce weight before another treatment.

ESG Compared with Weight-Loss Medication

Modern weight-loss medications, many given as weekly injections, act on appetite-regulating hormones rather than on stomach size. In clinical trials, some of these medicines have produced weight loss that overlaps with, and in some cases exceeds, what is typically reported after ESG. However, weight is often regained when the medication is stopped, so they are usually regarded as long-term treatments. Side effects such as nausea, constipation and diarrhoea are common, access and cost vary by country, and they are not suitable for everyone.

ESG and medication are not mutually exclusive. Some specialists consider combining them, or using medication to support weight maintenance after a procedure, although evidence on combined approaches is still developing.

How Candidacy Is Usually Decided

There is no single rule that assigns a person to one treatment. Specialists usually consider:

• body mass index and weight history;
• weight-related conditions such as diabetes, high blood pressure, sleep apnoea or metabolic syndrome;
• existing reflux, hiatal hernia or previous stomach surgery;
• other medical conditions and anaesthetic risk;
• personal preferences about surgery, permanence and daily medication;
• readiness for long-term dietary change and follow-up.

National guidelines and local availability also shape which options are offered, and criteria differ between countries.

Setting Realistic Expectations

All of these options are aids to weight management rather than cures for obesity. Results vary widely from person to person, and published average figures cannot predict an individual result. In general terms:

• surgery tends to produce the largest weight loss, with the most long-term data;
• ESG usually produces moderate weight loss, with evidence extending to a few years;
• balloons produce shorter-term weight loss, with regain common after removal;
• medication can be effective while it is taken, with regain common after stopping.

With every option, support from a dietitian and clinical nutrition therapy improve the chance of lasting benefit.

Risks to Weigh for Each Option

Each approach carries its own risk profile. Surgery involves general anaesthesia, incisions and permanent anatomical change, with risks such as leaks, bleeding, reflux and nutritional deficiencies. ESG has a lower reported rate of serious complications, but bleeding, fluid collections or leaks can occur. Balloons can cause significant early nausea and, rarely, obstruction or other complications. Medications can cause gastrointestinal side effects and have specific contraindications. A specialist should explain these risks in the context of an individual’s health.

Recovery and Time Commitment

The practical demands of each option differ. After sleeve gastrectomy, people usually spend a short time in hospital and follow a staged diet for several weeks, with lifelong vitamin and mineral monitoring. After ESG, many go home the same day or the next day and move through a similar, often shorter, staged diet. A balloon typically requires two procedures, one to place it and one to remove it, with a difficult first few days for some people. Medication requires regular prescriptions, dose adjustments and monitoring for side effects, sometimes for years.

Whichever route is chosen, the time commitment extends well beyond the procedure itself. Regular appointments with a dietitian and medical team, physical activity and steady attention to eating habits and sleep are part of every realistic plan.

Evidence and Limits

The evidence base differs between options. Sleeve gastrectomy has been studied for many years in large populations. ESG has randomised trial data and multiple observational studies, but fewer long-term results. Newer weight-loss medications have strong trial data, though real-world long-term experience is still accumulating. Direct head-to-head trials comparing all of these approaches are limited, so many comparisons rely on separate studies with different patient groups.

Questions to Ask a Specialist

• Which options are realistic given this weight, health history and preferences?
• How does the expected weight loss differ between ESG, surgery, a balloon and medication?
• Which option carries the lowest risk in this particular case?
• What happens if the chosen treatment does not work well enough?
• How long will follow-up and dietary support continue?

Related reading: gastric bypass.

FAQ

Q: Is ESG better than sleeve gastrectomy?

A: Neither is better for everyone. Sleeve gastrectomy generally leads to more weight loss and has more long-term evidence, while ESG is less invasive, does not remove tissue and usually has a quicker recovery.

Q: Is ESG permanent like a sleeve gastrectomy?

A: ESG is intended to be long-lasting, but it does not permanently remove any part of the stomach, and stitches can loosen over time. Sleeve gastrectomy is irreversible.

Q: How is ESG different from a gastric balloon?

A: A balloon is temporary and is removed or passed after a set period, whereas ESG reshapes the stomach with stitches that are meant to stay. Both are non-surgical approaches used for similar weight ranges.

Q: Can weight-loss medication replace ESG?

A: For some people, medication may be an alternative, and in trials some medicines have produced substantial weight loss. It usually needs to be continued long term, and weight is often regained after stopping.

Q: Can ESG and medication be combined?

A: Some specialists consider this, for example to support weight maintenance after ESG. Evidence on combined approaches is still limited, and decisions are made case by case.

Q: Which option causes the least reflux?

A: Sleeve gastrectomy is known to cause new or worsened reflux in some people. Studies suggest ESG is less likely to do so, but anyone with existing reflux should discuss it with a specialist.

Q: Who is usually a candidate for ESG rather than surgery?

A: ESG is often discussed for adults with moderate obesity, or those who are not suitable for or prefer to avoid surgery. People with higher weight or complex metabolic disease may be advised to consider surgery.

Q: Is follow-up needed with every option?

A: Yes. Whichever treatment is chosen, long-term dietary support, medical follow-up and lifestyle changes are central to lasting results.